Review





Similar Products

suprealq purple universal sybr qpcr master mix  (Vazyme Biotech Co)
95
Vazyme Biotech Co suprealq purple universal sybr qpcr master mix
Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by <t>quantitative</t> <t>PCR</t> (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Suprealq Purple Universal Sybr Qpcr Master Mix, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purple/pmc13103590-96-25-32?v=Vazyme+Biotech+Co
Average 95 stars, based on 1 article reviews
suprealq purple universal sybr qpcr master mix - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
purple loading dye  (New England Biolabs)
97
New England Biolabs purple loading dye
Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by <t>quantitative</t> <t>PCR</t> (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Purple Loading Dye, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purple/pmc13137149-27-0-4?v=New+England+Biolabs
Average 97 stars, based on 1 article reviews
purple loading dye - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier
dashed purple lines  (West Ward Pharmaceuticals)
86
West Ward Pharmaceuticals dashed purple lines
Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by <t>quantitative</t> <t>PCR</t> (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Dashed Purple Lines, supplied by West Ward Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purple/pmc13254859-115-2-8?v=West+Ward+Pharmaceuticals
Average 86 stars, based on 1 article reviews
dashed purple lines - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
purple top k edta microtainers  (Fisher Scientific)
86
Fisher Scientific purple top k edta microtainers
Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by <t>quantitative</t> <t>PCR</t> (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Purple Top K Edta Microtainers, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purple/pm42257268-67-9-14?v=Fisher+Scientific
Average 86 stars, based on 1 article reviews
purple top k edta microtainers - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
purple glove syndrome  (Pfizer Inc)
86
Pfizer Inc purple glove syndrome
Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by <t>quantitative</t> <t>PCR</t> (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Purple Glove Syndrome, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purple/pm42264008-30-20-26?v=Pfizer+Inc
Average 86 stars, based on 1 article reviews
purple glove syndrome - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
photocleavable jack staples purple  (Staples)
86
Staples photocleavable jack staples purple
Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by <t>quantitative</t> <t>PCR</t> (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Photocleavable Jack Staples Purple, supplied by Staples, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purple/pm42251060-867-0-2?v=Staples
Average 86 stars, based on 1 article reviews
photocleavable jack staples purple - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
mg l bromocresol purple  (Thermo Fisher)
94
Thermo Fisher mg l bromocresol purple
Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by <t>quantitative</t> <t>PCR</t> (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Mg L Bromocresol Purple, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purple/bio_rxiv__64898__2026__05__22__727108-111-13-36?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
mg l bromocresol purple - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
gravid purple sea urchins  (Marinus)
86
Marinus gravid purple sea urchins
Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by <t>quantitative</t> <t>PCR</t> (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Gravid Purple Sea Urchins, supplied by Marinus, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purple/bio_rxiv__64898__2026__05__14__725214-36-0-18?v=Marinus
Average 86 stars, based on 1 article reviews
gravid purple sea urchins - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
6x gel loading dye  (New England Biolabs)
97
New England Biolabs 6x gel loading dye
Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by <t>quantitative</t> <t>PCR</t> (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
6x Gel Loading Dye, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purple/pm42135407-155-5-10?v=New+England+Biolabs
Average 97 stars, based on 1 article reviews
6x gel loading dye - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier
prolume purple  (Prolume Ltd)
86
Prolume Ltd prolume purple
Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by <t>quantitative</t> <t>PCR</t> (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
Prolume Purple, supplied by Prolume Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/purple/pm42115777-222-24-24?v=Prolume+Ltd
Average 86 stars, based on 1 article reviews
prolume purple - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

Image Search Results


Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by quantitative PCR (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Journal: Biochemistry and Biophysics Reports

Article Title: Oroxylin A ameliorates hepatic steatosis and non-alcoholic fatty liver disease through the regulation of CPT1A m 6 A methylation in hepatocytes

doi: 10.1016/j.bbrep.2026.102598

Figure Lengend Snippet: Oroxylin A suppressed de novo lipogenesis (DNL) in PA-induced hepatocytes. (A–D) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by quantitative PCR (n = 3). (E) Representative bands of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were examined by Western blotting (n = 3). (F–I) Quantification of protein expression in AML-12 cells (n = 3). PA (0.25 mM) was used in A-I. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Article Snippet: RNA was extracted from liver or AML-12 cell lysates and reverse transcribed into cDNA using HiScript IV All-in-One Ultra RT SuperMix. cDNA was amplified using SupRealQ Purple Universal SYBR qPCR Master Mix (Vazyme).

Techniques: Real-time Polymerase Chain Reaction, Western Blot, Expressing

Oroxylin A regulated the m 6 A demethylation of CPT1A mRNA in PA-stimulated hepatocytes. (A–F) The mRNA levels of m 6 A demethylation Writers in AML-12 cells were measured by quantitative PCR (n = 3). (G-J) The mRNA levels of m 6 A demethylating erasers in AML-12 cells were measured by quantitative PCR (n = 3). (K, L) The mRNA levels of m 6 A demethylation Readers in AML-12 cells were measured by quantitative PCR (n = 3). (M) m 6 A modification levels in AML-12 cells were measured by m 6 A dot blot hybridization. (N) The possible m 6 A modification sites of CPT1A mRNA were analyzed using an online website. PA (0.25 mM) was used in A-M. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Journal: Biochemistry and Biophysics Reports

Article Title: Oroxylin A ameliorates hepatic steatosis and non-alcoholic fatty liver disease through the regulation of CPT1A m 6 A methylation in hepatocytes

doi: 10.1016/j.bbrep.2026.102598

Figure Lengend Snippet: Oroxylin A regulated the m 6 A demethylation of CPT1A mRNA in PA-stimulated hepatocytes. (A–F) The mRNA levels of m 6 A demethylation Writers in AML-12 cells were measured by quantitative PCR (n = 3). (G-J) The mRNA levels of m 6 A demethylating erasers in AML-12 cells were measured by quantitative PCR (n = 3). (K, L) The mRNA levels of m 6 A demethylation Readers in AML-12 cells were measured by quantitative PCR (n = 3). (M) m 6 A modification levels in AML-12 cells were measured by m 6 A dot blot hybridization. (N) The possible m 6 A modification sites of CPT1A mRNA were analyzed using an online website. PA (0.25 mM) was used in A-M. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Article Snippet: RNA was extracted from liver or AML-12 cell lysates and reverse transcribed into cDNA using HiScript IV All-in-One Ultra RT SuperMix. cDNA was amplified using SupRealQ Purple Universal SYBR qPCR Master Mix (Vazyme).

Techniques: Real-time Polymerase Chain Reaction, Modification, Dot Blot, Hybridization

Oroxylin A-regulated YTHDC1-mediated m6A modification of CPT1A contributes to a reduction in lipid metabolism in hepatocytes. YTHDC1 siRNA was used for YTHDC1 silencing. (A) The mRNA levels of YTHDC1 in AML-12 cells were measured by quantitative PCR (n = 3). (B–E) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by quantitative PCR (n = 3). (F, G) TC and TG levels in AML-12 cells. (H) Lipid droplet accumulation in AML-12 cells was examined by Oil Red O staining (n = 3). PA (0.25 mM) was used in A-M. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Journal: Biochemistry and Biophysics Reports

Article Title: Oroxylin A ameliorates hepatic steatosis and non-alcoholic fatty liver disease through the regulation of CPT1A m 6 A methylation in hepatocytes

doi: 10.1016/j.bbrep.2026.102598

Figure Lengend Snippet: Oroxylin A-regulated YTHDC1-mediated m6A modification of CPT1A contributes to a reduction in lipid metabolism in hepatocytes. YTHDC1 siRNA was used for YTHDC1 silencing. (A) The mRNA levels of YTHDC1 in AML-12 cells were measured by quantitative PCR (n = 3). (B–E) The mRNA levels of CPT-1A, PPARα, SREBP1-C and FASN in AML-12 cells were measured by quantitative PCR (n = 3). (F, G) TC and TG levels in AML-12 cells. (H) Lipid droplet accumulation in AML-12 cells was examined by Oil Red O staining (n = 3). PA (0.25 mM) was used in A-M. Data are presented as the mean ± SD. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.

Article Snippet: RNA was extracted from liver or AML-12 cell lysates and reverse transcribed into cDNA using HiScript IV All-in-One Ultra RT SuperMix. cDNA was amplified using SupRealQ Purple Universal SYBR qPCR Master Mix (Vazyme).

Techniques: Modification, Real-time Polymerase Chain Reaction, Staining